| Phenotype | Cases numbers refer to 'any prostate cancer'. Of those, 716 had aggressive prostate cancer (Gleason score ≥7, PSA ≥ 10 ng/mL, T3–T4 stage, nodal metastases, or distant metastases) and 57 had fatal prostate cancer. Death was determined by the investigators of each contributing study using cancer registries and/or medical records. Age shows the age of diagnosis. 1028 individuals had a family history of prostate cancer (≥1 first degree relative affected). |
| Sample Ancestry | Asian unspecified, NR |
| Total number | 2,382 individuals |
| Detailed numbers |
1,197 cases (50.25%)
1,185 controls
100.0% Male samples
|
| Age of Study Participants |
|
| Number of Cohort(s) | 60 |
| Cohort Short Name | Cohort Full Name | Previous/other/additional names (e.g. sub-cohorts) |
|---|---|---|
| Aarhus | Aarhus | — |
| AHS | Agricultural Health Study | — |
| ATBC | Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study | — |
| BioVU | BioVU, the Vanderbilt DNA Databank project | — |
| CCI | CCI | — |
| CeRePP | French Prostate Cancer Case-Control Study | — |
| CHIPGECS | Chinese Prostate Cancer Genetic and Environmental Correlation Study | — |
| COH | City of Hope Cancer Centre | — |
| CONOR | Cohort of Adults in Norway | — |
| COSM | Cohort of Swedish Men | — |
| CPCS | Copenhagen Prostate Cancer Study | — |
| CPDR | Center for Prostate Disease Research | — |
| EPIC | European Prospective Investigation into Cancer | — |
| EPICAP | Epidemiology of Prostate Cancer | — |
| ERSPC | European Randomised Study of Screening for Prostate Cancer | — |
| ESTHER | Epidemiological investigations on chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population / Epidemiologische Studie zu Chancen der Verhütung, Früherkennung und optimierten Therapie chronischer Erkrankungen in der älteren Bevölkerung, Verlauf der diagnotischen Abklärung bei Krebspatienten | Epidemiological investigations of the chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population (ESTHER_ELDERLY), Epidemiologische Studie zu Chancen der Verhütung, Früherkennung und optimierten Therapie chronischer Erkrankungen in der älteren Bevölkerung, Verlauf der diagnotischen Abklärung bei Krebspatienten (ESTHER-VERDI) |
| FHCRC | Fred Hutchinson Cancer Research Center, Seattle US | — |
| Gene-PARE | Genetic Predictors of Adverse Radiotherapy Effects | — |
| HPFS | Health Professional Follow-up Study | — |
| IMPACT | Identification of Men with a genetic predisposition to ProstAte Cancer | — |
| IPO-Porto | IPO-Porto Prostate Cancer study | — |
| KARUPROSTATE | French West Indies Prostate cancer Study (from Karukera, the original Caribbean name of Guadeloupe) | — |
| KULEUVEN | Katholieke Universiteit Leuven | — |
| LAAPC | Los Angeles Study of Aggressive Prostate Cancer | — |
| MCCS | Melbourne Collaborative Cohort Study | — |
| MCC-Spain | Multi-case Control Study, Spain | — |
| MDACCS | MD Anderson Cancer Center Study | — |
| MEC | Multiethnic Cohort Study of Diet and Health | — |
| MOFFITT | The Moffitt Group | — |
| NMHS | Nashville Men's Health Study | — |
| PASS | Prostate Active Surveillance Study | — |
| PCaP | North Carolina-Louisiana Prostate Cancer Project Consortium | — |
| PCMUS | Prostate Cancer study Medical University Sofia | — |
| PCPT | Prostate Cancer Prevention Trial | SWOG-PCPT |
| PHS | Physicians Health Study | — |
| PLCO | Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial | — |
| PRAGGA | Prostate Cancer Genetics in Galacia | — |
| PROCAP | PROgression in Cancer of the Prostate | — |
| PROFILE | Genetic Prostate cancer risk stratification for targeted screening | — |
| PROGReSS_PrCa | Prostate Cancer Group, Santiago, Spain | — |
| ProMPT | Prostate cancer : Mechanisms of progression and Treatment (UK) | — |
| ProtecT | Prostate testing for cancer and Treatment study | — |
| PROtEuS | Prostate Cancer and Environment Study | — |
| QLD | Queensland Study | — |
| RAPPER | Radiogenomics: Assessment of Polymorphisms for Predicting the effects of radiotherapy | — |
| SABOR | San Antonio Center of Biomarkers of Risk for Prostate Cancer | — |
| SCCS | NBHS/Southern Community Cohort | — |
| SCPCS | South Carolina Prostate Cancer Study | — |
| SEARCH | Study of Epidemiology and Risk Factors in Cancer Heredity | — |
| SELECT | Selenium and Vitamin E Cancer Prevention Trial | — |
| SFPCS | San Francisco Prostate Cancer Study | — |
| SNP_Prostate_Ghent | SNP Prostate Ghent (Belgium) | — |
| SPAG | Serum Proteomic analysis for biomarkers of Aggressive prostate disease in the Guernsey population | — |
| STHM | The Stockholm Study | STHM1, STHM2, Stockholm-1, Stockholm-2, STHLM, STHLM2 |
| TAMPERE | Tampere University Hospital | — |
| Toronto | Toronto | — |
| UKGPCS | UK Genetic Prostate Cancer Study | — |
| ULM | Center of Excellence-Baden-Wuerttemberg Type 2 Diabetes Cohort | — |
| WFPCS | Wake Forest Prostate Cancer Study | — |
| WUGS | Washington University Genetics Study | — |